We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 12.96% |
| 3 | Financials | 11.29% |
| 4 | Healthcare | 10.46% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
326
DELISTED
Avadel Pharmaceuticals
AVDL
| $71.9K | 0.02% |
+8,900
| New | +$78.5K |
|
327
Nucor
NUE
$59.1B
| $71.4K | 0.02% |
1,723
-501
| -23% | -$20.2K |
|
328
PUT
Meta Platforms (Facebook)
META
$1.72T
| $70.9K | 0.02% |
256
+216
| +540% | +$45.1K |
|
329
General Motors
GM
$74B
| $70K | 0.02% |
2,768
-1,059
| -28% | -$25.8K |
|
330
Masco
MAS
$13.5B
| $70K | 0.02% |
1,394
-3,993
| -74% | -$173K |
|
331
Encompass Health
EHC
$12.2B
| $68.9K | 0.02% |
1,399
| – | – |
|
332
Teleflex
TFX
$5.42B
| $68.4K | 0.02% |
188
-300
| -61% | -$104K |
|
|
AMRN
333
Amarin Corp
AMRN
$292M
| $67.3K | 0.02% |
486
+120
| +33% | +$16.5K |
|
334
Fidelity National Information Services
FIS
$19B
| $65.8K | 0.02% |
491
-1,374
| -74% | -$180K |
|
335
Teva Pharmaceutical Industries Limited
TEVA
$44.9B
| $64.8K | 0.02% |
5,255
-39,807
| -88% | -$450K |
|
336
Polaris
PII
$3.15B
| $63.9K | 0.02% |
690
-1,912
| -73% | -$146K |
|
337
Invitation Homes
INVH
$16.1B
| $63.3K | 0.02% |
2,301
-6,444
| -74% | -$161K |
|
338
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
| $61.3K | 0.02% |
751
+651
| +651% | +$52.5K |
|
339
Planet Fitness
PLNT
$3.78B
| $60.9K | 0.02% |
1,006
| – | – |
|
340
Target
TGT
$70.3B
| $60.8K | 0.02% |
507
-431
| -46% | -$49.2K |
|
341
Starbucks
SBUX
$111B
| $60.3K | 0.02% |
819
-226
| -22% | -$17K |
|
|
DBVT
342
DBV Technologies
DBVT
$741M
| $57.1K | 0.02% |
1,300
| – | – |
|
|
ZIV
343
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
| $57K | 0.02% |
2,000
| – | – |
|
344
Hartford Financial Services
HIG
$36.6B
| $56.1K | 0.02% |
1,454
-416
| -22% | -$15.9K |
|
345
Aurinia Pharmaceuticals
AUPH
$2.26B
| $55.2K | 0.01% |
+3,400
| New | +$54.4K |
|
346
Zimmer Biomet
ZBH
$18.5B
| $53K | 0.01% |
457
-1,358
| -75% | -$156K |
|
347
HealthEquity
HQY
$7.94B
| $52.7K | 0.01% |
899
-2,624
| -74% | -$145K |
|
348
McKesson
MCK
$103B
| $52.3K | 0.01% |
341
-15,821
| -98% | -$2.28M |
|
349
Harley-Davidson
HOG
$2.79B
| $52.2K | 0.01% |
2,194
+2,085
| +1,913% | +$45.3K |
|
|
AAN.A
350
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $50.8K | 0.01% |
1,118
-3,169
| -74% | -$144K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.4M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.